dendrit
cell
dc
macrophag
addit
class
ii
molecul
express
nonprofession
apc
either
constitut
ie
thymic
cortic
medullari
epitheli
cell
upon
induct
interferon
ifn
ie
endotheli
cell
intestin
epitheli
cell
mast
cell
fibroblast
mhc
class
ii
molecul
meet
intend
tcell
receptor
tcr
cell
surfac
complex
seri
biosynthet
proteolyt
event
ensur
correct
assembl
traffick
peptid
load
class
ii
molecul
watt
wolf
ploegh
accordingli
endocyt
proteas
requir
function
class
ii
molecul
found
distinct
apc
type
case
ifn
induc
chapman
mhc
class
ii
product
consist
chain
fl
chain
dimer
shortli
synthesi
endoplasm
reticulum
er
creat
cleft
antigen
pepfid
captur
watt
wolf
ploegh
fig
newli
synthes
afldim
assembl
onto
scaffold
homotrimer
type
ii
membran
protein
invari
chain
ii
two
isoform
ii
mice
distinguish
altern
splice
ii
transcript
koch
osullivan
et
al
strubin
et
al
result
isoform
contain
extra
exon
exon
ctermin
ii
trimer
domain
shall
see
addit
domain
play
key
role
control
ofproteas
express
activ
apc
human
two
splice
variant
yield
two
protein
product
result
four
ii
isoforrn
ii
prevent
prematur
associ
class
ii
heterodim
peptid
unfold
segment
polypeptid
chain
er
mean
short
segment
lumen
region
design
clip
class
iiassoci
ii
deriv
peptid
fill
peptidebind
groov
class
ii
ghosh
et
al
interact
ii
also
facilit
fold
aflheterodim
cytoplasm
tail
ii
contain
target
signal
deliv
major
aflii
complex
transgolgi
network
tgn
directli
endocyt
pathway
bakk
dobberstein
benaroch
et
al
lotteau
et
al
newli
synthes
class
iiii
complex
fail
sort
instead
deliv
plasma
membran
follow
rapid
intern
endocyt
vesicl
castellino
germain
pinet
long
roch
et
al
zhong
et
al
thu
element
endocyt
pathway
receiv
flii
likewis
endocyt
compart
conrain
class
iiii
complex
differ
stage
matur
compos
much
pathway
travel
intern
antigen
watt
antigen
enter
endocyt
pathway
process
class
iipresent
peptid
resid
proteas
chapman
hard
fig
success
mhc
class
iirestrict
antigen
present
depend
avail
process
peptid
also
rate
ii
breakdown
remov
ii
must
proteolyt
destroy
free
class
peptidebind
groov
load
antigen
peptid
upon
arriv
ii
complex
endocyt
compart
ii
degrad
stagespecif
manner
combin
aspartyl
cystein
proteas
amigorena
et
al
maric
et
al
villadango
et
al
fig
class
ii
molecul
poor
substrat
proteas
peptidebind
cleft
afford
protect
proteolysi
content
complet
peptid
bind
class
ii
allel
requir
interact
nonclass
class
ii
dimer
refer
hereaft
dm
dm
induc
releas
ii
remnant
clip
facilit
load
antigen
peptid
alfonso
karlsson
busch
et
al
kropshof
et
al
peptid
longer
dislodg
dm
gener
pool
peptideload
class
ii
molecul
cell
surfac
fig
proteas
attack
ii
yield
class
iiii
intermedi
distinct
conform
requir
proper
traffick
interact
accessori
molecul
dm
acquisit
peptid
fig
ii
proteolysi
therefor
haphazard
instead
follow
welldefin
path
constanc
ii
intermedi
produc
proteolysi
facilit
identif
specif
proteas
capabl
perform
necessari
cleavag
yield
free
bind
peptid
cathepsin
ries
et
al
shi
et
al
l
nakagawa
et
al
f
shiet
al
shown
capabl
perform
critic
cleavag
late
stage
destruct
ofli
see
section
iii
hand
assign
specif
function
individu
proteas
gener
class
iirestrict
epitop
challeng
see
section
vi
rather
reli
function
singl
proteas
gener
peptid
given
antigen
may
requir
combin
sever
proteas
distinct
overlap
specif
villadango
ploegh
nonetheless
like
process
antigen
ii
execut
similar
endocyt
proteas
thu
antigen
present
pathway
class
ii
molecul
evolv
util
cell
proteolyt
housekeep
machineri
success
review
proteas
requir
ii
breakdown
remov
class
ii
like
import
process
antigen
class
iipresent
peptid
proteas
contain
endocyt
pathway
classifi
four
major
group
base
activesit
amino
acid
use
enzym
hydrolyz
amid
bond
protein
cystein
aspartyl
serin
metalloproteas
defin
intracellular
acid
proteas
refer
cathepsin
span
four
group
virtu
profess
apc
gener
peptideload
mhc
class
ii
molecul
endocyti
rout
mhc
class
ii
fldimer
synthes
endoplasm
retieulum
er
quickli
associ
homotrim
ii
form
nonamer
complex
aflii
clip
region
ii
lie
within
peptidebind
groov
afldim
nonamer
complex
exit
er
travers
golgi
stack
tgn
major
aflii
complex
deliv
directli
compart
endocyt
pathway
sort
signal
cytoplasm
tail
ii
complex
escap
cell
quickli
intern
endocyt
pathway
ii
remov
stepwis
fashion
combin
aspart
cystein
proteas
clip
region
ii
remain
class
ii
peptidebind
groov
aftclip
accessori
molecul
dm
interact
cflclip
black
arrow
intermedi
aftclip
gray
arrow
induc
releas
ii
remnant
continu
interact
dm
empti
class
ii
molecul
preserv
structur
facilit
load
antigen
peptid
peptid
load
onto
class
ii
gener
endocytos
antigen
antigen
must
first
partial
unfold
possibl
action
thiol
reduetas
gilt
render
protein
access
proteas
date
asparaginyl
endopeptidas
aep
cat
b
cat
cat
e
proteas
shown
import
vivo
gener
class
ii
present
peptid
result
aflpeptid
complex
deposit
cell
surfac
recognit
ceil
b
schemat
view
ii
breakdown
intermedi
isoform
ii
borken
indistinguish
manner
nonamer
class
iiii
complex
aflii
disrupt
coohtermin
degrad
ii
aspartyl
proteas
yield
afldim
attach
ii
degrad
intermedi
residu
subsequ
coohtermin
process
perform
cystein
proteas
yield
aftassoci
intermedi
specif
proteas
absolut
requir
process
step
known
cleavag
convert
clie
cleavag
perform
cat
b
cell
dc
macrophag
cat
l
etec
cat
f
digest
clip
vitro
may
function
backup
enzym
macrophag
lack
cat
harbor
mani
enzym
cathepsin
b
c
e
f
h
k
punturieri
et
al
l
v
z
x
identifi
variou
profession
apc
type
list
certainli
complet
turk
et
al
villadango
ploegh
enzym
identifi
profession
apc
cathepsin
e
aspartyl
proteas
remain
cathepsin
cat
cystein
proteas
belong
papain
famili
enzym
mcgrath
base
chromosom
locat
sequenc
homolog
cystein
proteas
subdivid
cat
blike
cat
llike
subgroup
cyglerand
mcgrath
classif
howev
appear
accur
mean
predict
cathepsin
could
play
role
ii
breakdown
andor
antigen
process
instanc
cathepsin
l
f
shown
capabl
perform
similar
ii
cleavag
see
although
cat
cat
l
belong
llike
subgroup
cat
f
distinct
wex
et
al
addit
cathepsin
member
legumain
famili
cystein
proteas
asparaginyl
endopeptidas
aep
also
present
apc
ie
b
cell
manouri
et
al
may
well
one
specif
enzym
term
prefer
cleavag
site
abund
cystein
aspartyl
proteas
express
apc
cathepsin
b
respect
mcgrath
structur
cathepsin
b
musil
et
al
l
fujishima
et
al
guncar
et
al
k
mcgrath
et
al
zhao
et
al
ti
mcgrath
et
al
determin
well
structur
procathepsin
b
podobnik
et
al
l
coulomb
et
al
k
mcgrath
matur
cathepsin
rang
kda
proenzym
amino
acid
larger
compos
two
equival
size
domain
stabil
presenc
disulfid
bond
two
domain
separ
catalyt
center
contain
activ
site
nucleophil
use
cleav
bound
substrat
specif
enzym
determin
architectur
activ
site
cathepsin
k
l
f
endopeptidas
hydrolyz
intern
amid
bond
protein
mcgrath
turk
et
al
catalysi
endoproteas
reli
triad
compos
cystein
histidin
asparagin
residu
histidin
asparagin
residu
polar
cystein
residu
gener
nucleophil
attack
carbonyl
carbon
target
amid
bond
substrat
mcgrath
turk
et
al
enzymat
activ
associ
open
activ
site
approxim
length
substrat
bind
mcgrath
turk
et
al
turk
et
al
contrast
aminoexopeptidas
activ
cat
h
cat
c
carboxylexopeptidas
activ
cat
b
cat
z
gener
obstruct
part
activ
site
side
chain
stabil
either
n
terminu
c
terminu
bound
substrat
mcgrath
turk
et
al
result
hydrolysi
one
two
amino
acid
either
peptid
termini
lower
ph
occlud
loop
cat
b
flexibl
allow
enzym
also
function
endopeptidas
illi
et
al
nagler
et
al
limit
endoproteolyt
activ
also
describ
cat
h
illi
et
al
mcgrath
howev
major
endoproteas
present
endocyt
pathway
aspart
proteas
cat
cystein
proteas
cat
cat
l
except
aep
lysosom
proteas
show
rather
relax
cleavag
specif
make
predict
cleavag
site
antigen
difficult
b
biosynthesi
activ
enzym
lysosom
proteas
synthes
er
inact
zymogen
proenzym
mcgrath
turk
et
al
propiec
vari
size
locat
n
terminu
matur
enzym
role
propiec
matur
precursor
enzym
activ
proteas
resembl
chaperon
ii
mhc
class
ii
matur
er
inact
proteas
requir
propiec
effici
fold
assembl
fold
class
ii
dimer
facilit
ii
tao
et
al
vernet
et
al
furthermor
clip
region
ii
lie
peptidebind
cleft
class
ii
dimer
propeptid
appropri
length
occupi
activ
site
enzym
occup
activ
site
prevent
prematur
activ
enzym
travel
golgi
way
endocyt
pathway
coulomb
et
al
lalond
et
al
turk
et
al
enzymat
function
proteas
peptidebind
function
class
ii
cqdimer
requir
activ
site
liber
occup
propiec
clip
event
occur
endocyt
pathway
cathepsin
exit
er
travel
golgi
acquir
posttransl
modif
includ
glycosyl
phosphoryl
influenc
presenc
propiec
gieselmann
et
al
lingeman
et
al
modif
requir
proper
sort
proteas
tgn
phosphomannosyl
residu
proteas
bind
two
type
mannos
receptor
shuttl
golgi
endocyt
compart
kasper
et
al
koster
et
al
pohlmann
et
al
deposit
endocyt
compart
propiec
remov
spontan
autocatalyt
mechan
action
anoth
proteas
yield
matur
activ
form
enzym
one
chain
two
chain
depend
enzym
lalond
et
al
ries
chapman
thu
cathepsin
mhc
class
ii
molecul
render
function
endocyt
pathway
proteolyt
event
inhibit
class
ii
peptid
load
agent
rais
ph
acid
intracellular
organel
first
evid
success
class
iirestrict
antigen
present
reli
function
endocyt
proteas
neet
es
et
al
wolf
ploegh
mention
propiec
lysosom
proteas
must
remov
activ
enzym
whether
cleavag
propeptid
occur
autocatalysi
action
anoth
proteas
acid
ph
necessari
thought
proton
group
adjac
propeptid
low
ph
may
increas
suscept
propeptid
cleavag
altern
tertiari
structur
proenzym
may
chang
decreas
ph
render
propeptid
vulner
cleavag
ph
vacuolar
organel
eukaryot
includ
endosom
lysosom
tgn
maintain
atpdepend
proton
pump
known
vacuolar
hatpas
nelson
neutral
compart
acidotrop
drug
chloroquin
ammonium
chlorid
thoren
vassal
carboxyl
ionophor
monensin
nigericin
tartakoff
prevent
lysosom
proteas
function
turn
class
iirestfict
antigen
present
select
inhibitor
vacuolar
hatpas
includ
macrolid
antibiot
bafilomycin
eoncanamycin
b
bowman
et
al
woo
et
al
yoshimori
et
al
inactiv
vacuolar
hatpas
mammalian
cell
agent
affect
ph
also
format
endosom
carrier
vesicl
well
sort
event
tgn
benaroch
et
al
mellman
et
al
henc
acid
ph
andor
proteas
function
endocyt
pathway
import
intracellular
transport
protein
includ
sort
recycl
endosom
although
acid
ph
requir
remov
propiec
therebi
activ
enzym
cathepsin
uniqu
maintain
enzymat
function
neutral
ph
bromm
et
al
shi
et
al
featur
cat
befit
critic
role
ii
process
discuss
prerequisit
load
class
ii
molecul
antigen
peptid
class
iiii
complex
cat
present
varieti
endocyt
structur
earli
endosom
rel
high
ph
acid
lysosom
earlier
experi
conduct
larg
b
cell
place
consider
emphasi
late
endosom
compart
proteolysi
ii
matur
class
ii
molecul
clear
earli
endosom
essenti
part
class
ii
antigen
present
pathway
brachet
et
al
pond
watt
henc
ph
flexibl
cat
principl
enabl
class
ii
peptid
load
varieti
endocyt
compart
express
mhc
class
ii
molecul
key
accessori
compon
class
ii
antigen
present
pathway
induc
accordingli
regul
express
mani
cathepsin
critic
role
antigen
present
cathepsin
l
f
chapman
shi
et
al
express
cat
b
li
bever
cat
h
lafus
eta
cat
w
chapman
also
induc
ifn
cytokin
shown
rais
ph
earli
endosom
could
infuenc
pattern
ii
process
compart
fuch
et
al
although
test
moreov
treatment
dc
appear
influenc
type
ofepitop
deriv
hen
egg
lysosom
hel
present
class
ii
molecul
drakesmith
et
al
although
mechan
influenc
antigen
present
known
alter
endosom
ph
could
affect
type
peptid
gener
intact
antigen
andor
could
influenc
peptideedit
function
accessori
molecul
dm
develop
immatur
dc
incap
antigen
present
apc
support
antigen
present
class
ii
molecul
requir
action
proinflammatori
cytokin
turn
cytokin
induc
dc
matur
also
regul
activ
proteas
particip
ii
antigen
process
proinflammatori
cytokin
tumor
necrosi
factor
tnfct
illfl
rapidli
increas
activ
cat
cat
b
human
dc
promot
class
ii
peptid
load
present
cell
surfac
fiebig
et
al
contrast
antiinflammatori
cytolan
attenu
level
cat
b
cat
dc
fiebig
et
al
like
seem
inhibit
proteas
activ
dc
elev
ph
endocyt
pathway
fiebig
et
al
earlier
studi
demonstr
peptid
load
murin
class
ii
molecul
ia
k
immatur
dc
could
induc
upon
exposur
tnf
inaba
et
al
henc
balanc
proand
antiinflammatori
cytokin
dc
consequ
cellular
proteolyt
activ
strictli
correl
antigen
present
certain
cathepsin
exhibit
tissuespecif
express
favor
particip
antigen
present
activ
cat
present
predominantli
bone
marrowderiv
apc
b
cell
dc
macrophag
accordingli
cat
key
enzym
requir
late
stage
ii
proteolysi
apc
type
shiet
al
contrast
activ
cat
l
found
naiv
b
cell
dc
hut
rather
macrophag
cortic
thymic
epitheli
cell
shiet
al
cat
l
play
central
role
ii
degrad
thymu
necessari
class
iimedi
select
matur
cell
locat
nakagawa
et
al
addit
cystein
proteas
cat
f
capabl
perform
cleavag
ii
cat
vitro
preferenti
activ
ifnyinduc
alveolar
macrophag
shi
et
al
express
level
cathepsin
macrophag
regul
level
transcript
andor
enzym
matur
activ
macrophag
either
increas
decreas
intracellular
level
cathepsin
well
induc
cathepsin
secret
extracellular
space
therebi
regul
intracefular
extracellular
proteolyt
potenti
apc
liuzzo
et
al
wang
et
al
regul
proteolysi
macrophag
dc
relev
antigen
present
also
affect
microenviron
apc
inde
releas
cathepsin
macrophag
serv
remodel
extracellular
matrix
guid
cell
motil
three
type
endogen
cystein
proteas
inhibitor
present
apc
bind
tightli
revers
enzym
activ
site
enzym
propiec
cystatin
superfamili
ofinhibitor
fragment
exon
isoform
ii
discuss
section
vi
chapman
et
al
propeptid
cystatin
bind
enzym
activ
site
revers
orient
natur
substrat
stubb
et
al
prevent
digest
enzym
occupi
activ
site
propiec
appear
function
inhibitor
enzym
reach
acid
compart
upon
propiec
selfdissoci
cleav
evid
releas
propiec
resid
endocyt
pathway
regul
activ
resid
proteas
cystatin
perhap
studi
endogen
cystein
proteas
inhibitor
turk
bode
play
essenti
role
protect
cell
tissu
inappropri
proteolysi
enzym
overexpress
escap
endocyt
pathway
turk
et
al
appropri
cystatin
express
throughout
bodi
tissuespecif
manner
greatli
outnumb
cystein
proteas
cytoplasm
extracellular
space
mutat
cystatin
alter
balanc
cognat
cystein
proteas
implic
sever
diseas
huh
et
al
cystatin
also
inactiv
cystein
proteas
made
pathogen
therebi
may
serv
defens
mechan
infect
collin
grubb
korant
et
al
stoka
et
al
hand
cystatinlik
proteas
inhibitor
made
pathogen
also
modul
proteas
content
process
antigen
apc
manouri
et
al
cystatin
superfamili
cystein
proteas
inhibitor
includ
stefin
subfamili
class
cystatin
b
cystatin
subfamili
class
ii
cystatin
c
kininogen
subfamili
class
iii
brown
dziegielewska
two
new
class
ii
cystatin
defin
cystatin
e
cystatin
f
leukocystatin
whose
express
restrict
hematopoiet
cell
halfon
et
al
sotiropoul
et
al
although
cystatin
mention
target
cystein
proteas
cathepsin
b
f
k
l
h
cystatin
c
shown
also
inhibit
asparaginyl
endopeptidas
alvarezfernandez
et
al
intrigu
unusu
long
propiec
cat
f
addit
normal
cat
llike
propiec
domain
cat
f
uniqu
propiec
addit
aminotermin
domain
resembl
cystatin
thu
cystatinlik
domain
cat
f
may
serv
inhibit
zymogen
form
enzym
also
upon
remov
endocyt
pathway
may
function
inhibitor
cystein
proteas
mechan
cystatin
inhibit
cystein
proteas
reveal
determin
threedimension
structur
complex
human
cystatin
b
papain
stubb
et
al
three
highli
conserv
region
inhibitor
two
rigid
hairpin
loop
flexibl
ntermin
region
molecul
form
wedg
bind
activ
site
cystein
proteas
major
ofproteas
exhibit
open
activ
site
cystatin
bind
inhibit
enzym
onestep
reaction
mechan
bjork
ylinenjarvi
lindahl
et
al
pol
et
al
turk
et
al
turk
et
al
turk
et
al
proteas
partial
obstruct
activ
site
cat
b
cat
h
access
endogen
inhibitor
illi
et
al
quraishi
et
al
case
cystatin
inhibit
via
twostep
reaction
mechan
consist
initi
weak
bind
follow
conform
chang
displac
occlud
loop
activ
site
tight
complex
form
inhibitor
enzym
musil
et
al
nycand
et
al
pavlova
et
al
recent
surg
attent
given
cystein
proteas
immunologist
led
discoveri
cystatin
thought
primarili
function
extracellular
space
may
also
play
role
regul
proteolyt
environ
endocyt
pathway
thu
turn
antigen
present
dendrit
cell
perhap
potent
apc
bodi
distinct
abil
present
antigen
via
class
ii
molecul
tightli
coordin
matur
theri
amigorena
although
immatur
dendrit
cell
abil
take
process
antigen
peptid
gener
fail
present
stabl
fashion
cell
surfac
class
ii
molecul
result
one
studi
indic
ii
degrad
cat
inhibit
immatur
dc
b
haplotyp
increas
express
cystatin
c
pierr
mellman
addit
studi
shown
defect
load
ofia
k
molecul
hel
epitop
immatur
dc
remedi
upon
induct
dc
matur
inflammatori
mediat
inaba
et
al
unclear
whether
peptideload
defect
seen
ia
k
immatur
dc
result
aberr
process
hel
caus
cystatin
c
inhibit
cat
inaba
et
al
like
mechan
besid
cat
inhibit
cystatin
c
influenc
traffick
class
ii
molecul
dc
cat
dc
matur
complex
accumul
lysosom
eventu
deposit
cell
surfac
mark
contrast
fate
complex
immatur
dc
complex
retain
lysosom
degrad
suggest
factor
contribut
retent
class
ii
molecul
immatur
dc
villadango
ploegh
studi
recent
report
villadango
et
al
demonstr
class
iipeptid
complex
fact
gener
immatur
dc
deliv
cell
surfac
howev
contrast
matur
dc
class
iipeptid
complex
deposit
surfac
immatur
dc
rapidli
endocytos
degrad
thu
rate
endocytosi
rather
ii
proteolysi
regul
cystatin
c
may
dictat
antigen
present
capabl
immatur
versu
matur
dc
villadango
et
al
final
cathepsin
like
regul
activ
one
anoth
recent
honey
et
al
demonstr
absenc
cat
level
activ
cat
l
protein
increas
thu
cat
could
play
role
degrad
matur
cat
l
shown
competit
inhibitor
also
exhibit
chaperon
function
vivo
isoform
ii
protect
matur
form
cat
l
see
whether
gener
proteaseinhibitor
complex
vivo
remain
establish
experi
past
reli
inhibitor
broad
substrat
specif
demonstr
involv
cystein
proteas
antigen
present
physiolog
process
inhibitor
includ
synthet
compound
leupeptin
benzyloxycarbonylphealadiazomethan
although
potent
inhibitor
ofcystein
proteas
serv
distinguish
activ
site
similar
close
relat
cathepsin
cat
l
cat
much
effort
devot
develop
analog
inhibitor
visual
enzymat
activ
particular
cathepsin
distinct
cell
type
enzymat
mechan
util
cystein
proteas
conserv
well
defin
enabl
develop
wide
rang
electrophil
substrat
analog
reactiv
conserv
activ
site
cystein
proteas
bogyo
et
al
greenbaum
et
al
inhibitor
consist
peptid
specif
determin
attach
electrophil
becom
irrevers
alkyl
bound
close
proxim
attack
nucleophil
bogyo
et
al
mechanismbas
inhibitor
includ
vinyl
sulfon
palmer
et
al
epoxysuccin
deriv
barrett
eta
dimethyl
keton
deriv
pliura
et
al
shaw
shaw
et
al
engin
inhibitor
contain
affin
label
radioact
iodin
biotin
use
probe
measur
proteas
activ
distinct
tissu
bogyo
et
al
greenbaum
et
al
summar
tabl
activ
sitedirect
probe
measur
function
known
cathepsin
also
serv
identifi
new
activ
proteas
given
pathway
affinitylabel
version
activ
sitedirect
inhibitor
nmorpholinurealeucinehomophenylalaninevinyl
sulfonephenyl
lhv
jpm
tabl
iodin
biotinyl
use
success
obtain
profil
cathepsin
activ
distinct
apc
type
driessen
et
al
shiet
al
lennondumenil
submit
public
inhibitor
coval
bind
activ
site
ofcystein
proteas
membraneperm
peptid
vinyl
sulfon
lhv
specif
inhibit
cat
nanomolar
concentr
cat
b
lesser
extent
palmer
et
al
higher
concentr
specif
lhv
extend
addit
cystein
proteas
includ
cat
l
felbor
et
al
submit
public
analog
natur
product
peptid
epoxid
inhibit
known
lysosom
cystein
proteas
coval
modifi
activesit
nucleophil
barrett
et
al
membran
permeabl
exhibit
gener
specif
cystein
proteas
bogyo
et
al
greenbaum
et
al
activ
cystein
proteas
present
cell
lysat
coval
modifi
lhv
affinitylabel
probe
label
enzym
separ
sdspage
visual
either
autoradiographi
label
bogyo
et
al
dfiessen
et
al
shiet
al
blot
streptavidinhorseradish
peroxidas
follow
chemiluminescens
label
lhv
lennondumenil
et
al
pwb
unpublish
data
sinc
coval
modif
lhv
mechan
base
label
probe
proport
enzymat
activ
proteas
target
palmer
et
al
recent
develop
includ
synthesi
fluoresc
probe
afford
multiplex
visual
proteolyt
activ
live
cell
bogyo
person
commun
addit
analog
peptideepoxidebas
inhibitor
includ
cat
bspecif
inhibitor
compound
design
mimic
carboxytermin
dipeptid
replac
termin
guanidinobutylamin
prolin
residu
termin
chain
free
carboxyl
group
towatari
et
al
bind
peptid
portion
cat
b
activ
site
invers
orient
observ
epoxidecontain
inhibitor
famili
turk
et
al
specif
achiev
tight
bind
compos
two
h
bond
ctermin
prolin
two
highli
conserv
histidin
residu
occlud
loop
cat
b
turk
et
al
increas
membran
permeabl
cat
bspecif
inhibitor
analog
prolin
freeacid
group
convert
methyl
ester
gener
use
vivo
measur
cat
b
activ
buttl
et
al
recent
new
peptid
epoxid
develop
replac
isopropyl
moieti
phenol
group
site
attach
radioact
iodin
yield
affinitylabel
probe
studi
cat
b
activ
bogyo
et
al
seri
epoxysuccinatebas
cat
land
cat
sspecif
inhibitor
also
develop
design
clik
katunuma
et
al
repres
inhibitor
seri
shown
first
deriv
use
primesit
nonprimesit
interact
along
enzym
activesit
cleft
inhibit
cat
l
exclus
specif
cat
l
come
ntermin
pyridin
final
use
model
analog
synthes
vari
core
peptid
recognit
sequenc
ad
affin
tag
distal
site
result
probe
maintain
gener
cystein
proteas
specif
parent
compound
moreov
librari
deriv
construct
posit
leucin
main
specif
determin
mani
cystein
proteas
replac
differ
amino
acid
librari
use
obtain
activ
profil
multipl
proteas
crude
cellular
extract
final
group
wellcharacter
activ
sitedirect
inhibitor
membran
permeabl
diazomethyl
keton
cbztyralacnz
inhibitor
irrevers
bind
activ
site
cystein
proteas
proport
activ
iodin
version
compound
use
demonstr
activ
cystein
proteas
live
cell
mason
et
al
b
anoth
analog
peptidyl
diazomethan
probe
fmoc
produc
block
n
terminu
fmoc
group
permit
modif
probe
without
damag
diazomethan
group
crawford
et
al
xing
et
al
iodin
form
fmoc
react
specif
cat
b
cat
l
cat
use
affinitylabel
inhibitor
reveal
unlik
cat
b
cat
l
activ
site
cat
restrict
could
accommod
bulki
diiodotyrosin
inhibitor
xing
eta
advanc
inhibitor
probe
design
summar
provid
excit
prospect
assess
proteas
profil
cell
popul
avail
limit
number
subset
profession
apc
allow
construct
complet
catalog
proteas
relev
antigen
present
refin
inhibitor
may
ultim
yield
compound
suffici
select
block
singl
proteas
live
ceil
approach
nice
complement
genet
tool
avail
perhap
precis
tool
determ
cystein
proteas
requir
antigen
present
class
ii
molecul
mous
individu
cathepsin
gene
knock
mice
defici
cat
b
cat
saftig
et
al
cat
shi
et
al
cat
l
roth
et
al
cat
sl
shiet
al
cat
sb
driessen
et
al
press
gener
class
ii
antigen
present
pathway
mutant
mice
includ
intracellular
traffick
ii
process
antigen
process
peptid
load
present
studi
detail
vivo
model
proteas
function
quickli
expos
limit
vitro
studi
util
cultur
cell
cystein
proteas
inhibitor
mean
assign
function
individu
cathepsin
although
cathepsin
b
l
implic
vitro
studi
import
degrad
protein
antigen
class
ii
present
peptid
none
appear
indispens
vivo
likewis
abil
cat
b
cat
digest
ii
vitro
irrelev
ii
process
vivo
know
cat
bone
marrowderiv
apc
cat
l
cortic
thymic
epitheli
cell
nakagawa
et
al
requir
ratelimit
cleavag
step
late
stage
breakdown
ii
vivo
phenotyp
mice
regard
antigen
present
discuss
detail
follow
section
primari
function
ii
ensur
peptiderecept
class
ii
molecul
end
endocyt
pathway
class
ii
molecul
depend
ii
order
function
somewhat
paradox
chaperon
function
ii
format
class
ii
fldimer
requir
creat
peptiderecept
cleft
yet
physic
complex
form
ii
afldim
prevent
class
ii
molecul
bind
peptid
thu
function
proteas
destruct
ii
complex
reach
endocyt
pathway
indispens
requir
ii
abruptli
end
class
ii
molecul
deliv
peptidebind
destin
ii
contain
signal
retain
class
ii
molecul
endocyt
compart
peptideload
event
ensu
addit
occup
class
ii
peptidebind
groov
clip
fragment
ii
preserv
peptiderecept
statu
class
ii
fldimer
therebi
prevent
degrad
empti
class
ii
molecul
antigen
peptid
load
without
assist
dm
alfonso
karlsson
henc
proteas
must
coordin
digest
ii
way
preserv
peptiderecept
state
class
ii
fldimer
key
endocyt
proteas
particip
stepwis
degrad
ii
earli
experi
employ
proteas
inhibitor
broad
specif
reveal
import
cystein
aspartyl
proteas
ii
breakdown
amigorena
et
al
blum
cresswel
maric
et
al
neefj
ploegh
cat
b
cat
abund
endocyt
proteas
predict
major
enzym
involv
ii
proteolysi
inde
vitro
cat
b
cat
could
digest
ii
away
aflii
complex
either
cell
lysat
purifi
prepar
awa
cresswel
mizuochi
et
al
rey
et
al
roch
cresswel
howev
commerci
avail
enzym
prepar
use
initi
vitro
studi
prove
impur
contamin
less
abund
cathepsin
experi
use
pure
prepar
cat
b
cat
fail
reproduc
origin
result
neither
enzym
capabl
remov
ii
flii
complex
synthes
vitro
ries
et
al
still
vitro
experi
flaw
emul
vivo
level
andor
ratio
enzym
substrat
could
role
proteas
initi
ii
breakdown
render
ii
cleavag
site
access
key
enzym
assess
enzym
particip
ii
proteolysi
vivo
correctli
identifi
proteas
involv
ii
breakdown
vivo
mutant
mice
defici
distinct
cathepsin
analyz
proteolyt
digest
ii
apc
isol
mice
lack
either
cat
b
cat
villadango
et
al
unaffect
fact
phenotyp
mice
regard
rate
ii
digest
type
proteolyt
intermedi
gener
indistinguish
wildtyp
mice
henc
despit
copiou
level
apc
neither
cat
b
cat
essenti
normal
ii
remov
vivo
proteolyt
convers
cflii
molecul
aflpeptid
complex
larg
dissect
perform
pulsechas
experi
apc
follow
immunoprecipit
class
iiii
complex
differ
time
chase
reveal
proteolyt
step
remov
ii
class
ii
molecul
matur
apc
analyz
biochem
experi
treat
specif
proteas
inhibitor
result
accumul
ii
breakdown
intermedi
morton
et
al
neefj
ploegh
villadango
et
al
repres
normal
intermedi
ii
process
ie
occur
uninhibit
cell
stall
ii
process
inhibit
specif
proteas
mere
allow
captur
detect
ii
fragment
remain
associ
class
ii
molecul
coprecipit
afldim
visual
sdspage
ident
ii
process
intermedi
determin
molecular
weight
reactiv
antibodi
specif
distinct
region
intact
ii
uniqu
featur
certain
class
ii
allel
ie
routin
ia
b
human
bound
termin
ii
breakdown
intermedi
well
peptid
stabil
complex
sd
intact
complex
visual
sdspage
immunoprecipit
complex
boil
prior
separ
sadeghnasseri
germain
experi
conduct
mous
human
apc
led
model
stepwis
degrad
intact
ii
final
end
product
clip
depict
fig
ries
chapman
villadango
et
al
first
step
ii
process
involv
unravel
class
iiii
nonamer
complex
deliv
earli
endosom
framework
complex
ii
homotrim
held
togeth
via
trimer
domain
locat
ctermin
clip
individu
ii
homotrim
attach
one
class
ii
fldimer
via
clip
region
dimer
peptidebind
groov
proteolyt
cleavag
carboxytermin
region
ii
result
disrupt
homotrim
thu
nonamer
complex
monomer
aflii
complex
noncystein
proteas
respons
earli
ii
process
event
cystein
proteas
inhibitor
leupeptin
prevent
elimin
ctermin
trimer
region
blum
cresswel
maric
et
al
villadango
et
al
howev
ident
proteas
involv
remain
unknown
although
cat
mice
exhibit
defect
ii
process
villadango
et
al
inhibitor
aspart
proteas
affect
ii
breakdown
maric
et
al
zhang
et
al
cat
e
possibl
aep
may
particip
earli
cleavag
event
step
subsequ
first
carboxytermin
cleavag
leupeptin
sensit
thu
reli
cystein
proteas
sever
class
iiassoci
ii
breakdown
intermedi
accumul
apc
treat
leupeptin
blum
cresswel
neefj
ploegh
first
predomin
intermedi
ntermin
fragment
result
remov
coohtermin
trimer
domain
aspart
proteas
fragment
span
residu
intact
ii
detect
readili
human
apc
haplotyp
mice
villadango
et
al
second
major
ii
intermedi
accumul
presenc
ofleupeptin
approxim
kda
fragment
begin
ii
extend
coohterminu
clip
residu
villadango
et
al
process
intermedi
kda
also
accumul
bone
marrowderiv
mous
apc
villadango
et
al
data
support
precursorproduct
relationship
ii
process
intermedi
preced
proce
cystein
proteas
absolut
essenti
convers
vivo
still
known
treatment
apc
leupeptin
uncov
two
key
ii
process
step
requir
cystein
proteas
convers
digest
degrad
end
product
aflcli
flclip
gener
presenc
leupeptin
sinc
cystein
proteas
cat
express
primarili
apc
express
induc
upregul
class
ii
express
cat
consid
like
particip
late
stage
ii
breakdown
inde
treatment
b
cell
dc
cat
sspecif
inhibitor
lhv
bromm
mcgrath
result
accumul
complex
ries
et
al
villadango
et
al
moreov
complex
isol
lhvstreat
apc
could
convert
vitro
flclip
digest
recombin
cat
ries
et
al
henc
serv
vivo
substrat
cat
complet
ii
proteolysi
unlik
cat
b
cat
abil
cat
cleav
complex
flclip
vitro
held
true
vivo
bulk
ii
process
stall
stage
bone
marrowderiv
apc
isol
cat
b
mice
shi
et
al
lesser
extent
also
accumul
absenc
cat
indic
although
absolut
requir
cat
mediat
process
intermedi
wherea
accumul
preferenti
earli
late
endosom
accumul
lysosom
compart
despit
accumul
complex
cat
apc
tflpeptid
complex
eventu
detect
cell
surfac
albeit
consider
delay
wolf
bryant
et
al
submit
public
defect
peptideload
extend
beyond
kinet
includ
type
epitop
could
present
class
ii
molecul
mutant
mice
shi
et
al
despit
defect
observ
ii
proteolysi
cat
sdefici
b
cell
tcell
select
cat
mice
unaffect
mutat
normal
number
cell
found
peripher
lymphoid
compart
shi
et
al
tcell
posit
select
migrat
thymu
recognit
class
iipeptid
self
complex
express
cortic
thymic
epitheli
cell
proteas
requir
late
stage
ii
process
tissu
specif
wherea
cat
requir
convert
gflclip
bmderiv
b
cell
dc
cat
l
requir
cleavag
ctec
nakagawa
et
al
thu
explain
tcell
select
normal
cat
mice
cat
l
also
express
macrophag
along
cat
inde
defect
ii
breakdown
seen
cat
b
cell
sever
cat
macrophag
shiet
al
howev
ii
process
defect
pronounc
macrophag
alveolar
periton
isol
cat
sl
doubledefici
mice
singl
cat
macrophag
shi
et
al
cat
macrophag
treat
ifn
express
cat
f
digest
cqclip
least
vitro
shi
et
al
rate
convers
peptid
reflect
respons
enzym
effici
gener
cclip
wolf
bryant
et
al
submit
public
cat
still
far
effici
prefer
proteas
gener
clip
even
macrophag
cat
f
run
close
second
requir
cat
gener
clip
complex
tissu
celltyp
specif
also
vari
wide
among
class
ii
allel
class
ii
allel
iaq
ia
k
ia
u
ia
less
depend
cat
effici
ii
remov
subsequ
peptid
load
ia
b
villadango
et
al
remov
clip
peptidebind
groov
class
ii
allel
subsequ
load
antigen
peptid
catalyz
accessori
molecul
dm
alfonso
karlsson
busch
et
al
dmdefici
anim
ia
b
molecul
occupi
clip
fungleung
et
al
martin
et
al
miyazaki
et
al
depend
dm
clippeptid
exchang
allel
specif
physic
interact
dm
class
ii
molecul
requir
exchang
clip
antigen
peptid
later
aspect
dm
bind
region
near
n
terminu
class
ii
peptidebind
cleft
guerra
et
al
mosyak
et
al
kinet
analysi
dmmediat
clippeptid
exchang
vogt
et
al
suggest
interact
dm
impart
opentransit
state
class
ii
peptidebind
cleft
favor
clip
releas
crystal
structur
iadclip
suggest
breakag
hydrogen
bond
n
terminu
peptidebind
groov
clip
would
suffic
mediat
clip
releas
mosyak
et
al
loss
singl
h
bond
posit
ia
chain
two
h
bond
suffici
render
ia
incap
stabl
interact
clip
antigen
peptid
ova
chang
class
ii
structur
impos
mutat
may
exemplifi
type
alter
mediat
dm
interact
enabl
clippeptid
exchang
minim
conform
requir
dm
vivo
substrat
studi
date
identifi
vivo
substrat
dm
dm
interact
class
ii
molecul
associ
intact
ii
thu
ii
proteolysi
prerequisit
dm
function
ident
dm
substrat
found
dm
mice
alon
dm
mice
contain
function
complet
repertoir
endocyt
proteas
thu
degrad
iabassoci
ii
proce
complet
regardless
dm
mutat
therefor
accumul
abclip
complex
dm
apc
mere
emphas
requir
dm
liber
peptidebind
groov
ia
b
stage
ii
remov
known
whether
dm
interact
ii
breakdown
intermedi
upstream
clip
vivo
vitro
dm
could
exchang
ii
breakdown
intermedi
complex
human
class
ii
molecul
addit
clip
denzin
cresswel
denzin
et
al
howev
accumul
complex
cat
apc
togeth
delay
appear
aftpeptid
complex
cell
surfac
shi
et
al
suggest
dm
prefer
either
substrat
rather
termin
ii
process
intermedi
clip
thu
appear
aflpeptid
complex
surfac
cat
apc
dm
depend
could
result
one
two
mechan
first
yet
unknown
enzym
distinct
cat
gener
aftclip
substrat
use
dm
may
present
b
cell
altern
dm
may
exchang
antigen
peptid
process
intermedi
clip
albeit
consider
less
effici
success
deliveri
mhc
class
ii
molecul
compart
endosomalaysosom
pathway
reli
mainli
prior
associ
ii
bakk
dobberstein
lotteau
et
al
ii
contain
two
leucinebas
signal
cytoplasm
tail
confer
specif
target
function
bremn
et
al
odorizzi
et
al
cytosol
factor
interact
ii
tail
thu
direct
traffick
event
yet
identifi
chain
adaptor
protein
complex
provid
specif
clathrin
assembl
recogn
sort
motif
cytoplasm
domain
membran
protein
interact
if
cytoplasm
tail
vitro
hofmann
et
al
whether
interact
occur
live
cell
remain
demonstr
ii
also
affect
architectur
endocyt
pathway
attribut
may
play
role
antigen
process
andor
present
express
high
level
ii
induc
format
larg
endocyt
compart
call
macrosom
pieter
et
al
romagnoli
et
al
macrosom
format
correl
delay
transport
protein
earli
endosom
late
endosomeslysosom
gorvel
et
al
romagnoli
et
al
langerhan
cell
apc
found
contain
larg
acid
vesicl
presenc
macrosom
apc
correl
high
rate
ii
synthesi
kampgen
et
al
moreov
format
macrosom
depend
trimer
ii
geddedahl
et
al
properti
requir
proper
deliveri
cqii
complex
endosom
compart
thu
like
trimer
cytoplasm
tail
ii
interact
compon
molecular
machineri
involv
membran
traffic
identifi
compon
recent
synthes
affin
matrix
trimer
ii
cytoplasm
tail
forc
chemic
approach
allow
us
identifi
one
cytosol
partner
capabl
interact
ii
et
al
submit
public
initi
identifi
uncoat
atpas
dissoci
clathrin
triskelion
clathrin
coatedvesicl
schlossman
et
al
analysi
clathrinco
vesicl
cycl
cell
express
atpasedefici
mutant
suggest
protein
may
also
requir
chaperon
cytosol
clathrin
triskelion
allow
recruit
coat
pit
newmyer
schmid
abil
ii
recruit
activ
might
caus
uncoat
therebi
inhibit
subsequ
fission
reaction
essenti
retriev
vesicular
constitu
would
shift
balanc
toward
fusion
lead
increas
size
target
organel
carri
ii
seen
co
cell
express
ii
inde
express
dominantneg
version
iitransfect
co
cell
counteract
abil
ii
modifi
endocyt
pathway
demonstr
interact
vivo
ii
part
machineri
vesicular
transport
et
al
submit
public
earlier
studi
postul
role
peptid
deliveri
class
ii
molecul
panjwani
et
al
yet
unidentifi
mechan
recent
data
suggest
role
extend
mainten
properli
organ
endocyt
pathway
manner
contribut
mhc
class
iirestriet
antigen
present
dendrit
cell
isol
cat
mice
exploit
model
dissect
role
proteas
traffick
matur
class
ii
molecul
along
endocyt
rout
immunofluoresc
subcellular
fraction
experi
demonstr
absenc
cat
class
ii
molecul
complex
ntermin
fragment
ii
mainli
accumul
lateendocyt
compart
dc
find
reminisc
earlier
studi
conduct
leupeptintr
b
cell
immatur
bmderiv
dc
retent
class
ii
molecul
lateendocyt
compart
correl
low
activ
cystein
proteas
gener
brachet
et
al
cat
pierr
mellman
henc
ii
proteolysi
must
proceed
order
fashion
end
stage
clip
ensur
proper
traffick
class
ii
molecul
endocyti
rout
furthermor
cell
biolog
studi
refer
prove
activ
cat
restrict
lateendocyt
compart
instead
found
along
endocyt
rout
dc
includ
earli
endosom
intracellular
distribut
cat
agre
uniqu
abil
remain
activ
neutral
ph
thu
convers
aftclip
could
occur
varieti
endocyt
compart
enabl
class
ii
molecul
sampl
distinct
pool
differenti
compartment
antigen
peptid
sinc
addit
ii
intermedi
also
accumul
late
compart
cat
dc
fragment
ii
may
repres
addit
substrat
cat
cat
govern
mhc
class
ii
traffick
via
role
ii
degrad
also
affect
architectur
endoeyt
vesicl
independ
class
iiii
dc
isol
cat
mice
exhibit
increas
level
lateendocyt
marker
lampl
analyz
confoc
microscopi
correl
increas
flhexosaminidas
activ
fraction
cat
dc
thorough
morpholog
examin
endocyt
vesicl
cat
cell
conduct
use
electron
microscopi
strike
result
compart
stain
lateendocyt
marker
consider
enlarg
cat
cell
compar
wildtyp
cell
e
peter
person
commun
sinc
cytoplasm
tail
ii
respons
bind
remain
intact
cat
dc
note
fragment
retain
element
tempt
propos
recruit
uncoat
atpas
account
abnorm
morpholog
induct
enlarg
lateendocyt
vesicl
absenc
cat
may
parallel
format
macrosom
observ
iitransfect
co
cell
whose
format
reli
interact
ii
either
cat
play
direct
role
control
protein
traffick
along
endocyt
pathway
enlarg
endocyt
compart
observ
cat
cell
mere
result
accumul
class
ii
complex
recruit
answer
await
gener
character
cat
x
ii
doubl
knockout
mice
far
emphas
degre
class
ii
antigen
present
pathway
exploit
normal
housekeep
function
cell
specif
proteolysi
purpos
success
proper
traffick
class
ii
complex
endocyt
vesicl
ii
breakdown
peptid
acquisit
function
cell
proteas
indispens
howev
immun
system
may
take
give
proteolyt
machineri
cell
may
exploit
compon
class
ii
antigen
present
pathway
benefit
discuss
recent
data
demonstr
role
ii
regul
proteolyt
environ
individu
apc
addit
indistinguish
function
chaperon
class
ii
fold
intracellular
traffick
peterson
miller
takaesu
et
al
takaesu
et
al
isoform
murin
ii
convert
clip
fineschi
et
al
takaesu
et
al
takaesu
et
al
presum
cat
express
differ
ratio
variou
type
apc
wherea
repres
total
pool
ii
splenocyt
express
level
consider
higher
macrophag
dc
langerhan
cell
kampgen
et
al
koch
harri
pierr
mellman
pure
et
al
segment
resembl
thyroglobulin
domain
rich
cystein
residu
osullivan
et
al
segment
found
noncoval
bound
matur
form
cat
l
purifi
human
kidney
ogrinc
et
al
crystal
structur
cat
l
complex
segment
complex
show
fragment
occupi
cat
l
activ
site
moreov
vitro
studi
demonstr
segment
inhibit
cat
l
enzymat
activ
bevec
et
al
fineschi
et
al
turk
et
al
function
relev
cat
associ
vivo
b
requir
full
cat
l
activ
lysosom
hydrolas
cat
l
synthes
er
proenzym
erickson
mcgrath
cat
l
proregion
consist
amino
acid
occupi
activesit
cleft
maintain
enzym
inact
state
coulomb
et
al
export
along
endocyt
pathway
procat
l
undergo
sever
proteolyt
cleavag
gener
cat
l
singlechain
kda
twochain
matur
form
compos
ofa
heavi
chain
link
light
chain
disulfid
bond
erickson
ishidoh
kominami
mcgrath
reilli
et
al
mutant
mous
strain
defici
ii
express
either
ii
develop
studi
function
isoform
antigen
present
takaesu
et
al
takaesu
et
al
use
anim
studi
function
signific
cat
interact
vivo
contrari
expect
cat
l
express
activ
strongli
reduc
apc
isol
iidefici
mice
measur
immunoblot
activesit
label
experi
lennondumenil
et
al
agreement
describ
cat
l
interact
matur
twochain
form
cat
l
depend
express
wildtyp
level
level
matur
cat
l
consider
decreas
endocyt
compart
cell
lack
isoform
ii
lennondumenil
et
al
level
matur
cat
l
decreas
absenc
question
address
perform
pulsechas
experi
presenc
differ
proteas
inhibitor
analys
show
absenc
cat
l
degrad
acid
compart
cystein
proteas
lennondumenil
et
al
submit
public
thu
appear
protect
cat
l
prematur
destruct
therefor
mere
inhibitor
cat
l
enzymat
activ
serv
chaperon
help
maintain
pool
matur
enzym
lateendocyt
compart
antigenpres
cell
prevent
cat
l
destruct
might
link
abil
bind
activ
site
cat
l
interact
reminisc
interact
cat
l
propeptid
maintain
enzym
inact
state
also
assist
fold
stabil
conform
jerala
et
al
mcgrath
procat
l
travers
endocyt
compart
attend
drop
ph
induc
conform
chang
propeptid
detach
cat
l
activ
site
cleav
gener
singlechain
form
enzym
jerala
et
al
even
though
remov
cat
l
propeptid
necessari
enzymat
activ
may
destabil
tertiari
structur
enzym
suffici
allow
partial
unfold
subsequ
degrad
lateendocyt
compart
may
function
cat
l
chaperon
unlik
propeptid
compart
neutral
ph
would
allow
cell
maintain
pool
latent
matur
cat
l
lateendocyt
compart
protect
destruct
hydrolas
data
demonstr
leupeptinsensit
cystein
proteas
control
turnov
cat
l
lateendocyt
compart
partial
degrad
matur
activ
form
lennondumenil
et
al
enzym
involv
process
level
cat
l
increas
bm
macrophag
cat
cat
b
knockout
mice
aml
unpublish
data
agreement
observ
recent
data
publish
honey
et
al
show
increas
cat
l
activ
cell
lack
cat
addit
cat
cat
b
cat
l
could
regul
level
activ
selfdegrad
context
would
exert
protect
effect
prevent
selfdestruct
matur
cat
l
present
antigen
requir
first
fragment
proteas
smaller
peptid
fit
easili
peptidebind
groov
mhc
molecul
mhc
class
ii
molecul
bind
present
peptid
deriv
antigen
gain
access
endocyt
pathway
endocytosi
phagocytosi
watt
wolf
ploegh
antigen
taken
apc
travers
endocyt
rout
via
vesicl
decreas
ph
gradual
exposur
antigen
increas
proteas
activ
ensur
antigen
complet
destroy
instead
broken
class
iipresent
peptid
mani
endocyt
compart
may
host
load
peptid
onto
class
ii
fldimer
given
fact
endocyt
vesicl
like
vari
proteolyt
content
coupl
differ
popul
antigen
hous
class
ii
molecul
ensur
access
divers
pool
antigen
peptid
moreov
locat
class
ii
molecul
becom
recept
peptid
load
may
determin
type
epitop
present
cell
contrast
detail
understand
ii
process
proteolyt
event
lead
gener
class
iipresent
peptid
intact
antigen
remain
somewhat
enigmat
nonetheless
gener
tcell
epitop
doubt
requir
specif
cleavag
cours
antigen
destruct
wherea
proteolyt
cleavag
requir
effici
ii
remov
class
ii
molecul
occur
late
stage
ii
breakdown
ie
clip
specif
cleavag
requir
ensur
gener
immunogen
epitop
intact
antigen
may
instead
need
earli
stage
antigen
process
see
antigen
acquisit
first
step
mhc
class
iirestrict
antigen
present
mechan
acquisit
occur
divers
mechan
regul
highli
specif
mode
antigen
uptak
apc
depend
sourc
antigen
type
apc
activ
state
apc
method
intern
util
dictat
endocyt
compart
antigen
target
mechan
antigen
uptak
either
specif
nonspecif
bakk
nordeng
nonspecif
uptak
involv
fluidphas
endocytosi
extracellular
fluid
primari
nonspecif
mechan
use
dc
intern
exogen
antigen
macropinocytosi
larg
volum
extracellular
fluid
engulf
macrosolut
captur
concentr
class
iiposit
endocyt
compart
sallusto
et
al
macropinocytosi
link
membraneruffl
activ
rather
uptak
mediat
clathrinco
pit
immatur
dc
intern
antigen
wherea
matur
dc
rather
function
present
result
peptid
cell
surfac
via
class
ii
molecul
theri
amigorena
specif
mechan
antigen
uptak
involv
endocytosi
phagocytosi
mediat
receptor
express
surfac
apc
bakk
nordeng
van
bergen
et
al
watt
type
profession
apc
b
cell
macrophag
dc
express
distinct
receptor
mediat
intern
exogen
antigen
summar
tabl
ii
receptor
includ
bcell
receptor
bcr
b
cell
fc
receptor
b
cell
macrophag
dc
member
macrophag
mannos
receptor
mmr
ctype
lectin
famili
macrophag
dc
receptor
serv
scaffold
concentr
antigen
intern
peptideload
compart
result
immun
respons
enhanc
sensit
fact
receptormedi
endocytosi
antigen
enabl
immun
system
respond
lower
antigen
concentr
compar
fluidphas
uptak
antigen
inde
allergen
present
cell
effect
allergen
target
via
allergenspecif
ige
fceri
apc
maurer
et
al
maurer
et
al
atop
individu
significantli
higher
level
fceri
cell
surfac
sever
apc
maurer
et
al
good
exampl
mechan
lower
individu
gregori
interact
receptor
ligand
lead
actin
polymer
phagosom
format
instanc
phagosom
develop
phagolysosom
fuse
earli
late
endosom
lysosom
host
cell
thu
content
becom
part
normal
endocyt
rout
travel
class
ii
molecul
phagosom
intracellular
bacteria
legioneua
mycobacterium
howev
exhibit
limit
fusion
host
cell
lysosom
ojciu
et
al
may
repres
mean
pathogen
evad
immun
respons
unlik
macrophag
dc
b
cell
exhibit
low
rate
pinocytosi
phagocytosi
compens
possess
antigenspecif
receptor
known
bcr
siemasko
clark
specif
bcr
allow
recogn
rare
lowaffin
antigen
antigen
capabl
crosslink
bcr
preferenti
captur
bcr
aggreg
enhanc
intern
bcr
compos
membran
ig
noncoval
associ
igcigfl
heterodim
membran
portion
recogn
bind
specif
antigen
heterodim
contain
immunoreceptor
tyrosinebas
activ
motif
initi
signal
cascad
necessari
intern
target
antigen
endocyt
compart
bcrantigen
complex
intern
via
clathrinco
pit
earli
endosom
sort
variou
endocyt
compart
contain
class
ii
molecul
sort
ag
earli
endosom
depend
signal
locat
cytoplasm
tail
igfl
wherea
deliveri
antigen
lateendocyt
vesicl
enrich
class
ii
molecul
requir
phosphoryl
tyrosin
residu
tail
ig
bakk
nordeng
siemasko
clark
fctr
receptor
util
profession
apc
facilit
enodyctosi
phagocytosi
immun
complex
amigorena
bonnerot
b
sever
type
fc
receptor
character
distinguish
part
cytoplasm
tail
sort
signal
signal
determin
intracellular
compart
ligand
bound
fc
receptor
deliv
bakk
nordeng
macrophag
dc
take
mannosyl
andor
fucosyl
antigen
via
mannos
receptor
upon
endocytosi
manos
receptorligand
complex
quickli
uncoupl
mannos
receptor
recycl
back
cell
surfac
intact
round
round
antigen
captur
intern
macrophag
mannos
receptor
primarili
recycl
peripher
earli
endosom
enger
et
al
tan
et
al
although
entri
late
endosom
observ
prigozi
et
al
bone
marrowderiv
dc
express
anoth
receptor
belong
mmr
famili
design
jiang
et
al
mahnk
et
al
contrast
mmr
deliv
antigen
late
endosom
lysosom
rich
mhc
class
ii
molecul
mahnk
et
al
acid
cluster
cytoplasm
tail
respons
intracellular
sort
function
target
function
ensur
antigen
class
ii
molecul
intersect
antigen
degrad
start
exposur
nativ
protein
low
ph
reduc
environ
dissoci
antigen
receptor
destabil
nativ
structur
disulfid
bound
must
reduc
unfold
protein
improv
access
proteolyt
enzym
fig
reduct
disulfid
bond
ratelimit
step
antigen
degrad
endocyt
compart
collin
et
al
jensen
jensen
lysosom
thiol
reductas
gilt
enzym
activ
low
ph
capabl
catalyz
disulfid
bond
reduct
vivo
vitro
gilt
express
constitut
antigenpres
cell
induc
ifn
cell
type
suggest
role
antigen
process
arunachalam
et
al
phan
et
al
redund
cleavag
specif
endocyt
proteas
made
identifi
enzym
requir
gener
specif
tcell
epitop
difficult
mhc
class
ii
peptidebind
cleft
open
end
therefor
accommod
peptid
variou
length
rang
residu
mani
residu
prefer
size
residu
characterist
peptid
bound
class
ii
consist
core
sequenc
rag
n
c
termini
suggest
one
enzym
respons
proteolysi
antigen
involv
initi
cleavag
endopeptidas
follow
sequenti
trim
end
aminoand
carboxypeptidas
watt
whether
specif
proteas
dedic
gener
class
iipresent
peptid
singl
antigen
requir
still
matter
debat
recent
aep
shown
initi
proteolyt
degrad
carboxytermin
domain
tetanu
toxin
antigen
ttcf
b
lymphoblast
antoni
et
al
manouri
et
al
cleavag
ttcf
singl
site
aep
shown
critic
gener
present
varieti
tcell
epitop
even
distant
cleavag
site
antoni
et
al
thu
singl
cleavag
aep
propos
unlock
nativ
ticf
structur
facilit
subsequ
degrad
present
peptid
undefin
proteas
antoni
et
al
given
strict
specif
aep
unlik
bulk
antigen
endur
proteolyt
fate
qtcf
know
concern
antigen
degrad
come
studi
perform
vitro
shown
ii
process
necessarili
mirror
take
place
vivo
vitro
cathepsin
b
e
gener
tcell
epitop
incub
intact
antigen
bennett
et
al
diment
van
noort
jacob
vidard
et
al
vivo
modest
shift
effici
present
antigen
determin
seen
apc
isol
cat
band
cat
ddefici
anim
nonetheless
overal
capac
cat
b
cat
apc
process
present
antigen
via
class
ii
molecul
unaffect
even
cat
apc
still
capabl
normal
antigen
present
epitop
test
shi
et
al
still
possibl
presenc
absenc
one
major
cathepsin
might
pivot
gener
immunogen
peptid
invad
pathogen
diseas
state
cat
b
import
degrad
peptid
protein
toxin
even
cell
surfac
receptor
enter
cell
via
endocytosi
phagocytosi
authier
et
al
mort
buttl
zhang
et
al
addit
activ
cat
shown
critic
present
pathogen
arthritisinduc
collagenderiv
epitop
iaq
mice
function
studi
use
specif
inhibitor
cat
e
show
enzym
essenti
process
ovalbumin
murin
cell
bennett
et
al
furthermor
regul
cat
e
human
bcell
activ
indic
cat
e
play
import
role
antigen
degrad
cell
seali
et
al
littl
evid
exist
role
cat
cat
l
antigen
degrad
vivo
possibl
cat
l
abil
degrad
extracellular
matrix
protein
might
import
patholog
condit
peptid
protein
present
inde
detect
small
popul
empti
class
ii
complex
cell
surfac
dc
rais
possibl
process
outsid
endocyt
pathway
could
also
play
role
class
iirestrict
antigen
santambrogio
et
al
b
addit
extracellular
proteas
may
trim
antigen
occupi
cleft
class
ii
molecul
alreadi
cell
surfac
thu
assist
gener
final
epitop
seen
cell
role
postul
aminopeptidas
n
apn
larsen
et
al
apn
capabl
digest
end
long
peptid
bound
cleft
class
ii
molecul
perhap
pronounc
defect
antigen
degrad
would
observ
apc
one
essenti
cathepsin
absent
studi
human
dc
high
concentr
activesit
inhibitor
lhv
concentr
inhibit
cat
cat
b
cat
l
indic
cat
cat
b
act
concertedli
degrad
antigen
fiebig
et
al
avoid
limit
inher
use
pharmacolog
inhibitor
cell
lysat
driessen
et
al
conduct
studi
contribut
cathepsin
b
l
degrad
antigen
could
assess
vivo
driessen
et
al
fate
radiolabel
immun
complex
f
ab
intern
fctr
follow
bone
marrowderiv
apc
isol
differ
cathepsin
mutant
mice
nonspecif
radiolabel
ab
degrad
rather
slowli
proteas
rel
stabl
peptid
intermedi
could
resolv
visual
sdspage
autoradiographi
result
show
cat
b
cat
mediat
bulk
lzsilabel
f
ab
degrad
via
independ
pathway
cat
l
cat
dispens
driessen
et
al
regardless
proteas
involv
antigen
unfold
subsequ
proteolysi
must
balanc
way
tcell
epitop
destin
present
class
ii
molecul
destroy
process
open
end
mhc
class
ii
bind
groov
allow
bind
longer
protein
fragment
tcell
epitop
lie
core
groov
thu
antigen
may
initi
digest
fragment
somewhat
longer
final
immunogen
peptid
peptidebind
groov
class
ii
tightli
enclos
helic
cleft
would
protect
degrad
end
fragment
hang
outsid
cleft
would
access
trim
endoand
exopeptidas
ie
cat
h
cat
b
thu
final
antigen
peptid
seen
cell
may
fulli
process
load
onto
class
ii
process
event
lead
peptideload
class
ii
molecul
defin
molecular
term
decad
work
field
lysosom
biolog
classif
essenti
proteas
definit
specif
design
specif
inhibitor
predat
immunologist
appreci
effort
class
iirestrict
antigen
present
complet
depend
lysosom
proteolysi
subject
offer
natur
blend
two
field
studi
exampl
draw
research
lysosom
biologist
immunologist
abl
determin
key
event
ii
proteolysi
clear
review
pictur
still
complet
proteas
involv
gener
intermedi
still
unknown
moreov
specif
proteolyt
requir
gener
tcell
epitop
intact
antigen
remain
unclear
possibl
proteolyt
digest
antigen
requir
action
compon
endocyt
pathway
chaperon
thiol
reductas
gilt
complet
pictur
molecular
cellular
requir
initi
antigenspecif
immun
respons
depend
continu
interact
field
lysosom
biolog
antigen
present
